Skip to content

Evaluation of Effect of Xiaozhi Hugan Capsule on Non-Alcoholic Steatohepatitis: a Randomized Controlled Trial

Evaluation of Effect of Xiaozhi Hugan Capsule on Non-Alcoholic Steatohepatitis: a Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052845
Enrollment
Unknown
Registered
2021-11-06
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Alcoholic Steatohepatitis

Interventions

Experimental group:Xiaozhi Hugan Capsule

Sponsors

The First Affiliated Hospital of He'nan University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Male or female, aged 18 to 65 years; 2. Conform to the diagnostic standards of Chinese and Western Medicine; 3. Fasting blood glucose <= 7.0 mmol/L; 4. Sign the informed consent form; 5. Did not take other drugs for the treatment of NASH in the past 4 weeks.

Exclusion criteria

Exclusion criteria: 1. Patients suffering from serious heart, brain, kidney, hematopoietic diseases, as well as anxiety, depression and other emotional diseases and mental illness; 2. Fatty liver caused by long-term use of glucocorticoids, chlorpromazine, insulin, etc.; 3. Patients with type I diabetes; 4. Patients with various malignant tumors or those with a history of malignant tumors; 5. Pregnant and lactating women; 6. Patients who are participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Alanine aminotransferase;Aspartate aminotransferase;Controlled attenuation parameter;

Secondary

MeasureTime frame
Symptom;Body mass index;Triglyceride;Total cholesterol;High density liptein cholesterol;

Countries

China

Contacts

Public ContactLiu Xiaoyan

The First Affiliated Hospital of He'nan University of Traditional Chinese Medicine

liuxiaoyan0917@126.com+86 18838994610

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026